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George Emil Palade
It is lyuboznanie 
(from Bulgarian, love to knowledge)
that drive us to find our Teacher
Magister dixit (Teacher said), used by Pythagoras’ 
students, expresses a respect to the Teacher. Socrates 
was the Teacher of Plato, Plato of Aristotle, Rita Levi-
Montalcini of Luigi Aloe, Harry Jellinek of Anna Kadar, 
Albert Claude of George Palade, George Palade of 
Günter Blobel and of many cell biologists worldwide. 
In 1981 I met with Palade during a coffee break of 
World Physiology Congress held in Budapest, Hungary, 
and said to him that I know each of words and micro-
graphs published in his articles on pancreatic exocrine 
secretion. They have driven my research on the secre-
tory pathway in vascular smooth muscle cells studied 
by electron microscopy (1972-1992). 
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Paradigm shifts in cell biology
According to the Stanford Encyclopedia of Philosophy, epistemol-
ogy (Greek epistēmē, meaning „knowledge“) is the study of knowl-
edge and justified belief. Also, the creation and dissemination of 
knowledge. An epistemological paradigm shift was called a „sci-
entific revolution“ by Thomas Kuhn in his book The Structure of 
Scientific Revolutions, its first edition being released in 1932 in the 
USA. Kuhn challenged the then prevailing view of progress in nor-
mal science, which was viewed as „development-by-accumulation“ 
of accepted facts and theories. Kuhn argued for a model in which 
periods of such conceptual continuity in normal science were inter-
rupted by periods of revolutionary science. A paradigms shift then 
emerged.
In the present lecture I will focus on three paradigm shifts, 
namely (i) the transition from light to transmission electron mi-
croscopy (TEM) in studying cell structures and functions made 
by Albert Claude, George Palade, Christian de Duve and Günter 
Blobel from the famous Rockefeller group in New York, (ii) the 
transition from contractile to secretory phenotype of vascular 
smooth muscle cells (VSMC), and (iii) the transition from lipid 
storage to secretory function of adipose tissue cells.
Seldom has a field owed so much to a single man 
In his paper published in 1971 George E. Palade wrote these 
words for Albert Claude, the founder of biological electron mi-
croscopic methodology (1). Now, I would like to articulate the 
same words for George Palade, thus expressing my in-depth 
homage to him, the scientific father of many generations in cell 
biology research and teaching.
George E. Palade was born on 19 November 1912 in Jassy, 
Northeastern Romania to a family that greatly valued education. 
His mother was a teacher and his father a professor of philoso-
phy, which explains why he acquired “a great respect for books, 
scholars, and education early in life” (2 and references therein). 
He graduated summa cum laude from Bucharest University 
Medical School in 1936. In 1945 his sapere aude (from Latin, 
dare to know) encouraged him to jump over the Iron Certain 
and land in the United States of America. There, at Rockefeller 
Institute for Medical Research (later renamed Rockefeller 
University) in New York, Palade joined Laboratory of Albert 
Claude (1945-1973), which he later dubbed “The American 
Cradle of Cell Biology”. Indeed, by this time and in this place 
was the blossom of TEM. Onward, Palade moved to Laboratory 
of Cell Biology, Yale University Medical School in New Haven, 
Connecticut (1973-1990) and Department of Cellular and 
Molecular Medicine, University of California at San Diego, La 
Jolla, California (1990-2002). For his discoveries of a new world 
of cell structures and their functions, George Palade was award-
ed 1974 Nobel Prize for Physiology or Medicine shared with 
Albert Claude and Christian de Duve.
In her concluding remarks Marilyn Farquhar wrote (2): 
“George Palade was truly “A Man for All Seasons.” He had broad 
interests and knowledge of science, the arts, and history. He died 
on October 7, 2008, at the age of 95 after a very full and produc-
tive life.  Palade believed that the most important thing in life is 
to “leave something behind for future generations,” and indeed 
he did. He is considered by many to be the father of modern cell 
biology and leaves behind an unparalleled legacy of discoveries. 
All these accomplishments and qualities made him, in the words 
of David Sabatini, “one of the most admired and beloved figures 
of our time”. 
     
GEORGE PALADE’S EUREKA!
• RIBOSOMES
• MITOCHONDRIA (Fig. 1)
•  ROUGH ENDOPLASMIC RETICULUM (RER) 
•  GOLGI COMPLEX AND GOLGI-DERIVED SECRETION 
VACUOLES (Fig. 2)
• SPECIFIC GRANULES IN ATRIAL MUSCLE CELLS
•  PLASMALEMMAL VESICLES (CAVEOLAE)
•  WEIBEL-PALADE BODIES IN ENDOTHELIAL CELLS
•  NEURONAL  SYNAPSES
• JUNCTIONAL COMPLEXES IN EPITHELIAL CELLS
• PROTEIN SECRETORY PATHWAY 
Overview of the secretory pathway
The secretion is a fundamental process in all cells, from the sim-
ple yeast to cells in human brain. On April 1898 Camillo Golgi 
communicated to the Medical-Surgical Society of Pavia, Italy, 
the discovery of the internal reticular apparatus, a novel intra-
cellular organelle which he observed in nerve cells with the sil-
ver impregnation (la reazione nera) he had introduced for the 
staining of the nerve cells (3). However, the real existence of this 
organelle (apparatus or complex) was seriously questioned un-
til it was finally identified by electron microscopy in the mid-
1950s, mainly due to the excellent work of George Palade (1, 2, 
4, Fig. 2). According to Palade’s classical concept (5) and Günter 
Blobel’s signal hypothesis (6), the protein secretory pathway 




Figure 1. Electron micrograph of a section through 
a mitochondrion in rat hepatocyte showing the cris-
tae, or “cristae mitochondriales,” which represent in-
foldings of the inner mitochondrial membrane. x100 
000). Image from the George E. Palade EM Collection. 
Figure 2. Electron micrograph 
of the Golgi complex in a pan-
creatic exocrine cell.  x 25 000 
Image from the George E. Pal-
ade EM Collection.
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Table 1.  The intracellular protein secretory pathway.
Table 2.  The two major protein secretory pathways.
ing, sorting, storage (in case of regulated versus constitutive 
secertion), translocation and, finally, exocytosis including 
porocytosis (7) mediated by porosomes (8). As mentioned, 
in 1974, the Nobel Prize was awarded to the Three Great 
„for their discoveries concerning the structural and func-
tional organization of the cell“, and in 1999 to the Fourth 
Great, Günter Blobel - „for the discovery that proteins have 
intrinsic signals that govern their transport and localization 
in the cell“.
The secretory proteins are three major subtypes: lysoso-
mal, plasmalemmal (including endosomal recycling pro-
teins) and exported, the latter being the focus of present 
lecture. The vast majority of exported proteins are processed 
by the RER-Golgi complex-TGN (trans-Golgi network)-
plasmalemma secretory route including sorting processes 
using signal recognition particle (SRP)-polysomes-signal 
peptide (SP) receptor-mediated interactions. These latter 
being Blobel’s topology of cell proteins (6). However, such 
a SRP-SP dependent protein secretion cannot explain the 
increasing number of SP-lacking proteins which are also ex-
ported such as growth factors  and cytokines. The process 
by which such SP-lacking, leaderless secretory proteins gain 
access to the cell exterior is termed unconventional protein 
secretion, which does not use Golgi-TGN processing (9). 
Intriguing examples of this secretion are extracellular vesi-
cles (a sort of signalosomes, also dubbed nanosomes): (i) 
exosomes, 30-200 nm vesicles derived from multivesicular 
bodies (10), and (ii) ectosomes (also named microparticles), 
100-900 nm vesicles shaded from plasma membrane (11), 
carrying important bioactive molecules, e.g. DNA, mRNA, 
microRNA, cytokines and immunoglobulins, to communi-
cate among cells via endocrine and paracrine way. Today, 
these talented vesicles are intensively studied by scientists in 
basic, translational and clinical research. 
Although the clearance of unfolded and missfolded pro-
teins via the ubiquitin-proteasome pathway (UPP) is very 
important for cell protein biology and this has been recog-
nized with the Nobel Prize for Chemistry awarded to Avram 
Hershko, Aaron Ciechanover and Irwin Rose in 2004, it is 
outside the scope of present lecture. 
Taken together the above data are illustrated in Table 1, 
2, Fig. 3, 4.
Chaldakov
Abbreviations: RER, rough endoplasmic reticulum; COP, 
coat protein complex, respectively COP I- and COP II-
coated vesicles. COP I-coated vesicles transport proteins 
from cis Golgi complex back to RER, and between Golgi 
compartments, a transport termed retrograde transport, 
in contrast to the anterograde transport associated with 
COP II-coated vesicles, which transport proteins from RER 
to Golgi complex.




All cells secrete some proteins 
The human body may be considered composed of mul-
tiple types of secretory cells delivering a large number 
of (neuro)peptides, proteins, proteoglycans, steroids and 
other signaling molecules, which control many biological 
processes in health and disease (12). Selected examples of 
such bona-fide multicrine cellular system are: (i) skeletal 
muscles - in response to contraction function as an en-
docrine and paracrine gland secreting various myokines 
including interleukin-6 (IL-6), IL-15, irisin, adiponectin, 
leukemia inhibitory factor, brain-derived neurotrophic 
factor (BDNF), myostatin (growth differentiation factor 
8, GDF-8), (ii) bone – osteocytes secrete the hormone 
osteocalcin, which modulates glucose metabolism and 
testosterone production, and fibroblast growth factor-23 
(FGF-23) that is involved in phosphate and vitamin D 
metabolism,   (iii) stomach mucosal cells secrete gastro-
kine (GKN1), GKN2, GKN3, also TFF1, TFF2, TFF3 (tre-
foil factor family domain containing  proteins), ghrelin 
(growth hormone-releasing peptide) and leptin, (iv) dif-
fuse neuroendocrine system (DNES), e.g. intestinal mu-
cosal cells (enteroendocrine cells) secrete the hormones 
incretins (glucagon-like peptide - GLP-1, GLP-2), glucose-
dependent insulinotropic polypeptide (GIP), also peptide 
tyrosine tyrosine (PYY), cholecystokinin, vasoactive in-
testinal peptide (VIP), somatostatin, motilin, nurotensin, 
serotonin, and the testicular Leydig-Davidoff cells, a new 
member of DNES, secrete testosterone, (v) hepatic stel-
late cells (Ito cells, perisinusoidal cells, fat- and vitamin 
A-storing cells) in liver injury modulate into fibrogenic 
(matrix protein-secreting) cells, critically involved in the 
pathogenesis of liver cirrhosis, (vi) gut microbial endo-
crine organ (12a, b) releases  trimethylamine-N-oxide, 
short chain fatty acids, bile acids, 4-ethyl phenyl sulfate, 
and mycotoxins (fungal toxins) (12c, d) which affected 
many organs, (vii) fibroblasts, chondrocytes, osteocytes, 
vascular smooth muscles and other fibrogenic cells se-
crete matrix proteins (procollagens, proelastin, fibrillin, 
fibronectin, etc), proteoglycans and glycosaminoglycans, 
and (viii) adipose tissue cells secrete more than 600 signal-
ing proteins collectively termed adipokines. 
Figure 5 illustrates schematically multicrine nature of a 
secretory cell.
Figure 4. Schematic presentation of intracellular targeting of 
proteins.
Abbreviations: RER, rough endoplasmic reticulum; GPI, glyco-
sylphosphatidylinositol – a protein (3) is co-translationally an-
chored via a GPI to the inner surface of RER membrane. Other 
proteins are indicated 1, 2, 4. From George N. Chaldakov’s 
Textbook of Cell Biology, 2nd edition. 2014 (in Bulgarian).
Figure 3. Diagram of intracellular pathway followed in the 
pancreatic exocrine cell of the guinea pig. Image from the 
George E. Palade EM Collection.
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Figure 5. A drawing illustrating multicrine and receptor 
feature of a secretory cell. Depending on its nature, the 
cell synthesizes, stores and releases, that is, secretes, some 
of the signalling proteins listed in the square. These com-
municate via multiple pathways, such as endocrine (ar-
rows 1, 4 and 5, from top to bottom), paracrine (arrow 2) 
and autocrine (arrow 3, curved); also shown are exosomes 
and ectosomes. Cell receptors for different ligands are 
depicted at right side of the figure. From (12). 
Figure 6. Electron micrographs of 
secretory-state (secretory pheno-
type) aortic smooth muscle cells 
of the rabbit. a. Well developed 
Golgi complex (G), b-e. Vacu-
oles with a fuzzy (probably not 
clathrin) coat (arrowheads and 
arrows). e. Vacuole-associated mi-
crotubules. a, x11 000; b, x30 000; 
c, x20  000; d, 45  000; e, x80  000. 
From (17).
Vascular biology: secretory phenotype smooth  
muscle cells
Paradigm shift in the research on vascular smooth muscle cells
In 1960 Maria Daria Haust and colleagues (13) published their 
seminal article suggesting the fibrogenic potential of VSMC as 
related to extracellular matrix production. Since then VSMC se-
cretion and proliferation have been increasingly studied as key 
cellular phenomena in the initiation and development of athero-
sclerosis. This concept was further sophisticated by Russell Ross 
(reviewed in 14). Of note, in the last 10-15 years a new paradigm 
shift is emerging in the field, for which we are preparing a paper 
tentatively entitled “Quo vadis, atherogenesis?”
In 1973 in Heidelberg, Germany, a Symposium on The Smooth 
Muscle of the Artery was held. There, as an invited speaker I have 
presented our own TEM findings about (i) Golgi-derived secre-
tion granules and coated vesicles, and (ii) cytoplasmic microtu-
bules in the secretory pathway of VSMC (15). Based on these and 
our further results (16-18), the term “secretion” was for the first 
time linked to VSMC function, and the concept of secretory pro-
cess as viewed by TEM (Fig. 6-11) introduced in VSMC biology. 
Later on it was appreciated by the vascular biology community, 




Figure 8. Electron micrographs of secretory-state (secretory phenotype) aortic smooth muscle cells of the rabbit. a. Golgi-as-
sociated clathrin-coated vesicles (arrows). b. Elongated vacuole linked via filamentous arms (two arrows) to microtubule. c. 
Plasmallema-derived coated pits (three arrows). d. Group of Golgi vesicles are sandwiched between microtubules. e. Rough 
endoplasmic reticulum-associated microtubules. a, c, d, x50 000; b, 80 000; e, 20 000. From (17).
Figure 7. Electron micrographs of secretory-state (secretory phenotype) aortic smooth muscle cells of the rabbit. a-e. Spherical-
shaped (arrows) and elongated-shaped (arrowheads) secretion granules. a-e, x20 000. From (17).
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which were not conceptually correct in sense of Palade’s data and 
understanding of cell protein secretion. Here is the great signifi-
cance to find the Teacher, and to creatively follow Him.
Microtubules are essential for the secretion in vascular 
smooth muscle cells
Our colchicine study for the first time aimed at the possible role 
of microtubules (MT) for VSMC secretory process in aortic 
arch, thoracic aorta and pulmonary trunk of 20-day-old rab-
bits. The rabbits were treated with a sub-antimitotic dose of 
colchicine, a tubulin-binding (antitubulin) substance leading to 
the disassembly of cytoplasmic MT. The VSMC of control, un-
treated rabbits showed well-developed RER and Golgi complex, 
and MT associated with Golgi-derived secretion granules (vac-
uoles) and with cisternae of RER (Fig. 6-8). Colchicine treat-
ment affected (i) MT in a monotypic way (all VSMC contained 
no MT after colchicine), and (ii) Golgi complexes and RER in 
a dual way, resulting in two major structural subpopulations of 
VSMC.  One subpopulation displayed a significant accumula-
tion of Golgi-derived secretion granules, whereas another sub-
population showed a vacuolar dilation of RER cisternae (16-18, 
Fig. 9-11). Moreover, these results may gain insight into a new 
pharmacotherapeutic approach directed to MT-disassembling 
agents (16-19).
Figure 9. Electron micrographs of secretory-state (secretory phenotype) aortic smooth muscle cells of the rabbit treated with a 
sub-antimitotic dose of colchicine. The cells responded to the treatment by (a) an accumulation of secretion granules (circles), 
or (b) vacuolar type dilation of rough endoplasmic reticulum (RER) cisternae, some of them approaching the cell periphery (1, 2, 
3), suggesting of a direct RER, not dependent on MT, way of exocytosis.  a, b, x10 000. From (17).
Adipobiology: most cell types of (white) adipose tissue 
are secretory in function
Leptin, Jeffrey Friedman and Adipose’s Big Bang 
On 1 December 1994 the ob gene in mice and its homolog in hu-
mans were “cloned officially” in Nature 372: 425–432, and 1995 
ob gene product purified and named leptin (from Greek leptos – 
thin), the first adipocyte-secreted hormone. In fact, adipsin was 
the first adipokine discovered (Cook KS, et al. Science 1987; 237: 
402-405). The seminal results related to ob gene and leptin were 
achieved by Jeffrey Friedman and coworkers in Laboratory 
of Molecular Genetics at Rockefeller University in New York. 
Leptin is released “classically” from white adipocytes (now also 
from gastric mucosal cells and cardiomyocytes) into the blood-
stream and acts on the brain. There leptin stimulates hypotha-
lamic anorexigenic neurons (mediated by cocaine- and amphet-
amine-regulated transcript - CART peptide and α-melanocyte-
stimulating hormone - α-MSH), whereas  inhibits orexigenic 
neurons (mediated by agouti gene-related protein - AgRP, mela-
nin-concentrating hormone – MCH, and neuropeptide tyrosine 
- NPY). This adipose-brain circuit maintains homeostatic con-
trol of food intake-energy expenditure, and adipose mass and 




Figure 10. Electron micrographs of secretory-state (secretory phenotype) aortic smooth muscle cells of the rabbit treated with 
colchicine. a. An aggregate of secretion vacuoles; arrows show electron dense material within the cavity of some vacuoles. 
 b. Encircled are cross-sectioned intermediated filaments; vacuoles (V). a, b, x20 000. From (17).
Figure 11. Electron micrograph of secretory-state (secretory phenotype) aortic smooth muscle cell of the rabbit treated with 
colchicine. This micrograph is a higher magnification of Figure 9b showing vacuolar dilation of rough endoplasmic reticulum 
cisternae, some of them (1, 2, 3) approaching progressively the cell periphery. From (17).
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In essence, the discovery of Jeffrey Friedman’s research group 
opens an exciting scientific avenue of endocrine and paracrine 
function of WAT. This is what I call Adipose’s Big Bang which is 
expanding through the human body, thus implicated in health 
and in the pathogenesis and therapy of cardiometabolic, neuro-
degenerative, cancer, liver, ovary and other diseases.
Periadventitial adipose tissue is, in fact, tunica adiposa 
of the vascular wall
In 1983 at the Department of Anatomy, University of Chicago 
Medical School, Chicago, IL, USA, I presented a lecture about 
the ultrastructure of secretory process in VSMC. During the 
discussion, a question whether adventitial fibroblasts may mi-
grate into the intima was raised. The answer of the lecturer was 
“I do not know. It seems impossible.” However, what seemed 
“impossible” in 1983 was proven possible in 1996 by Shi et al 
demonstrating that adventitial myofibroblasts may contribute to 
neointimat formation in coronary arteries (Circulation 1996; 94: 
1655-1664). 
Since 1998 we, together with our Italian BHF (Brain-and-
Heart Friends) Luigi Aloe and Marco Fiore, have been moving 
further “outside-in”, and proposed: “If signals and cells can be 
translocated from the adventitia into the intima, and hence lead 
to intimal lesions, then why not look for similar reactions from 
the artery-associated adipose tissue?” (20), the latter being des-
ignated tunica adiposa (21; Fig. 12). 
Recently, cardiometabolic diseases (atherosclerosis, hyper-
tension, obesity, type 2 diabetes and metabolic syndrome) are 
among the major physical, social and economic burdens, glob-
ally. Arguably, we have learned more about the molecular con-
trol of food intake and energy homeostasis, particularly the role 
played by adipose tissue in the pathogenesis of cardiometabolic 
and other diseases. This intellectual growth process was con-
ceptualized as adipobiology and adipopharmacology of disease 
(23). 
Today, it is know that about 30 % of genes in adipose cells 
(adipocytes, stromo-vascular cells, and associated immune 
cells) encoded for more than 600 exported secretory proteins 
collectively designated adipokines (20, 23). Altogether, recent 
studies have shifted the paridigm of WAT from simple lipid 
and energy storage to the body’s major endocrine and paracrine 
organ. Accordingly, two major sub-fields of adipobiology have 
emerged, adipoendocrinology and adipoparacrinology (24-26). 
The present challenge is therefore to cultivate secreto-centric 
thinking about how we can make VSMC secretion and adipose 
secretion work for the benefit of human’s health. This may in-
deed be a step forward but not the whole route in the systems 
biology of cell protein secretion. 
Whatever we move we have to most sincerely thank George 
Emil Palade. “Palade was an extraordinarily gifted and visionary 
Figure 12. Schematic presentation of vascular 
wall composed of four tissue coats (tunicae): 
intima, media, adventitia, and adiposa. Arrows 
showthat tunica media is a target for at least 
two vasorelaxing factors, endothelium-
derived relaxing factor (EDRF) and adipocyte-
derived relaxing factor (ADRF) respectively. 
Discontinuous black line positioned at the 
adventitia–media border illustrates perivascular 
nerves. Small-sized discontinuous black lines 
located in tunica adiposa indicate adipose 
nerves. Black granules (except those linked 
to arrows) illustrate immune cells – their 





scientist, and a generous mentor to several generations of scien-
tists who went on to stellar careers of their own. He was also an 
esteemed collaborator who earned the widespread respect and 
affection of colleagues the world over. He considered the train-
ing of new generations of scientists to be an important calling, 
based upon his belief that scientific discovery is “an enterprise 
that continues generation after generation.” (From George E. 
Palade lecture presented by Thomas Südhof, 2013 Nobel laure-
ate in Medicine, on 20 May 2014 at UCSD, USA.) 
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